143 related articles for article (PubMed ID: 38189554)
21. Identification of PANoptosis-related predictors for prognosis and tumor microenvironment by multiomics analysis in glioma.
Sun F; Liao M; Tao Z; Hu R; Qin J; Tao W; Liu W; Wang Y; Pi G; Lei J; Bao W; Dong Z
J Cancer; 2024; 15(9):2486-2504. PubMed ID: 38577605
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive Analyses of PANoptosome with Potential Implications in Cancer Prognosis and Immunotherapy.
Cai Y; Xiao H; Zhou Q; Lin J; Liang X; Xu W; Cao Y; Zhang X; Wang H
Biochem Genet; 2024 Mar; ():. PubMed ID: 38436818
[TBL] [Abstract][Full Text] [Related]
23. Machine learning reveals PANoptosis as a potential reporter and prognostic revealer of tumour microenvironment in lung adenocarcinoma.
Han C; Danzeng Q; Li L; Bai S; Zheng C
J Gene Med; 2024 Jan; 26(1):e3599. PubMed ID: 37800684
[TBL] [Abstract][Full Text] [Related]
24. Machine learning-based signature of necrosis-associated lncRNAs for prognostic and immunotherapy response prediction in cutaneous melanoma and tumor immune landscape characterization.
Cui Z; Liang Z; Song B; Zhu Y; Chen G; Gu Y; Liang B; Ma J; Song B
Front Endocrinol (Lausanne); 2023; 14():1180732. PubMed ID: 37229449
[TBL] [Abstract][Full Text] [Related]
25. Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology.
Mall R; Bynigeri RR; Karki R; Malireddi RKS; Sharma BR; Kanneganti TD
NAR Cancer; 2022 Dec; 4(4):zcac033. PubMed ID: 36329783
[TBL] [Abstract][Full Text] [Related]
26. The emerging role of PANoptosis in cancer treatment.
Xiong Y
Biomed Pharmacother; 2023 Dec; 168():115696. PubMed ID: 37837884
[TBL] [Abstract][Full Text] [Related]
27. Exploration of the prognostic prediction value of the PANoptosis-based risk score and its correlation with tumor immunity in lung adenocarcinoma.
Zhao X; Zhang X; Li F; Lu C
J Gene Med; 2024 Mar; 26(3):e3682. PubMed ID: 38508210
[TBL] [Abstract][Full Text] [Related]
28. PANoptosis: a potential new target for programmed cell death in breast cancer treatment and prognosis.
Liu X; Miao M; Sun J; Wu J; Qin X
Apoptosis; 2024 Apr; 29(3-4):277-288. PubMed ID: 38001342
[TBL] [Abstract][Full Text] [Related]
29. Expression patterns and immunological characterization of PANoptosis -related genes in gastric cancer.
Qing X; Jiang J; Yuan C; Xie K; Wang K
Front Endocrinol (Lausanne); 2023; 14():1222072. PubMed ID: 37664853
[TBL] [Abstract][Full Text] [Related]
30. Multiomics blueprint of PANoptosis in deciphering immune characteristics and prognosis stratification of glioma patients.
Chen M; Huang M; Chen X; Lin X; Chen X
J Gene Med; 2024 Jan; 26(1):e3621. PubMed ID: 37997255
[TBL] [Abstract][Full Text] [Related]
31. Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis).
Christgen S; Zheng M; Kesavardhana S; Karki R; Malireddi RKS; Banoth B; Place DE; Briard B; Sharma BR; Tuladhar S; Samir P; Burton A; Kanneganti TD
Front Cell Infect Microbiol; 2020; 10():237. PubMed ID: 32547960
[TBL] [Abstract][Full Text] [Related]
32. Identification of a PANoptosis-related Gene Signature for Predicting the Prognosis, Tumor Microenvironment and Therapy Response in Breast Cancer.
Yu T; Cheng W; Zhang J; Wang T; Liu Y; Duan Y; Hu A; Feng J; Li M; Li Y; Zhang H; Rong Z; Shang Y; Shakila SS; Ma F; Guo B
J Cancer; 2024; 15(2):428-443. PubMed ID: 38169571
[TBL] [Abstract][Full Text] [Related]
33. Caspase-8: A key protein of cross-talk signal way in "PANoptosis" in cancer.
Jiang M; Qi L; Li L; Wu Y; Song D; Li Y
Int J Cancer; 2021 Oct; 149(7):1408-1420. PubMed ID: 34028029
[TBL] [Abstract][Full Text] [Related]
34. Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment.
Zhu P; Ke ZR; Chen JX; Li SJ; Ma TL; Fan XL
Front Immunol; 2023; 14():1120034. PubMed ID: 36845112
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive Analysis of PANoptosis-Related Gene Signature of Ulcerative Colitis.
Wang JM; Yang J; Xia WY; Wang YM; Zhu YB; Huang Q; Feng T; Xie LS; Li SH; Liu SQ; Yu SG; Wu QF
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203518
[TBL] [Abstract][Full Text] [Related]
36. Construction and validation of a PANoptosis-related lncRNA signature for predicting prognosis and targeted drug response in thyroid cancer.
Li R; Zhao M; Sun M; Miao C; Lu J
PeerJ; 2023; 11():e15884. PubMed ID: 37671354
[TBL] [Abstract][Full Text] [Related]
37. PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatment.
Gao J; Xiong A; Liu J; Li X; Wang J; Zhang L; Liu Y; Xiong Y; Li G; He X
Cancer Gene Ther; 2024 Mar; ():. PubMed ID: 38553639
[TBL] [Abstract][Full Text] [Related]
38. PANoptosis: A Cell Death Characterized by Pyroptosis, Apoptosis, and Necroptosis.
Shi C; Cao P; Wang Y; Zhang Q; Zhang D; Wang Y; Wang L; Gong Z
J Inflamm Res; 2023; 16():1523-1532. PubMed ID: 37077221
[TBL] [Abstract][Full Text] [Related]
39. Caspase-6 is a key regulator of cross-talk signal way in PANoptosis in cancer.
Qi L; Wang L; Jin M; Jiang M; Li L; Li Y
Immunology; 2023 Jul; 169(3):245-259. PubMed ID: 36814103
[TBL] [Abstract][Full Text] [Related]
40. PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma.
Song F; Wang CG; Mao JZ; Wang TL; Liang XL; Hu CW; Zhang Y; Han L; Chen Z
Front Immunol; 2023; 14():1197152. PubMed ID: 37398672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
